Regulatory Strategy in The Pharmaceutical Industry: Paving the Way From Concept to Commercialization
-
Speaker : MOHAMMAD ELNADI
-
When : Wednesday, October 30, 2024
-
Time : 01 : 00 PM EST
-
Add To Calendar
Refer a Friend
Mohammad has a unique blend of both technical and regulatory experience and qualifications he gained from his +18 years’ experience in the pharmaceutical industry. After graduating in pharmaceutical science from the University of Cairo, He has held posts in the fields of R&D and production of pharmaceutical dosage forms and as a contract manufacturing coordinator then, after completing postgraduate certificate in management from the American university in Cairo (AUC). He has senior management roles in business development in pharmaceutical industry including opening new markets in local & export markets which allowed him to deal with different regulatory health authorities & business environments.
He successfully leaded his team in cooperation with colleagues from other departments within the companies in many market access projects in many African countries, ASEAN, GCC and other Middle East Countries.
Also, He was responsible for establishment of supply chain department in many pharmaceuticals Co. leading planning, local & foreign purchasing and warehouse functions in the company
Regulatory strategy in the pharmaceutical industry refers to the plan put in place by a pharmaceutical company to ensure compliance with laws, regulations, and guidelines set forth by regulatory agencies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe or any other relevant drug regulatory authorities.
Some key components of a successful regulatory strategy in the pharmaceutical industry include:
- Understanding and staying up-to-date with the relevant regulatory requirements and guidelines in the markets where the company operates.
- Planning and conducting comprehensive technical studies to generate the data needed to support regulatory submissions for drug approvals.
- Developing strong relationships with regulatory agencies to facilitate communication and collaboration throughout the drug development process.
- Establishing effective processes and systems for managing regulatory submissions, approvals, and compliance activities.
- Ensuring that all manufacturing and quality control processes meet regulatory standards to ensure the safety, efficacy, and quality of the company's products.
- Anticipating and preparing for potential regulatory challenges and changes that may impact the company's business operations.
Overall, a well-defined regulatory strategy is essential for pharmaceutical companies to successfully navigate the complex and highly regulated environment of the industry. It helps ensure that products are developed, manufactured, and marketed in compliance with all relevant regulations, ultimately leading to the successful commercialization of safe and effective medicines.
Areas Covered
- What is a regulatory strategy?
- Importance of regulatory strategy for pharmaceutical companies
- Principles of regulatory strategy development and implementation.
- Key components of the regulatory strategy
- Building strategy workflow
Who Should Attend
- Regulatory affairs professionals in the pharmaceutical industry.
- Business development professionals in the pharmaceutical industry.
Why Should You Attend
- How to develop a regulatory strategy for products in various stages of the product life cycle?
- How to analyze the strengths and weaknesses of a product in order to develop regulatory strategies and target product profiles?
- How to use best practices when communicating a regulatory strategy to the company project team or top management?
- Companies that have a strong regulatory strategy in place are better positioned to bring products to market quickly and efficiently.
- Understanding regulatory requirements can help streamline the product development and approval process, saving time and resources.
- By learning how to develop a regulatory strategy early on in the product development process, you can avoid common pitfalls and delays.
Topic Background
- A robust regulatory strategy bridges the gap between science-led innovation and the commercial reality of placing a product onto the market and making it commercially viable in the longer term so that patients benefit.
-
$199.00
-
